177 related articles for article (PubMed ID: 21338184)
21. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
22. Histological classification of liver and intrahepatic bile duct cancers in SEER registries.
Altekruse SF; Devesa SS; Dickie LA; McGlynn KA; Kleiner DE
J Registry Manag; 2011; 38(4):201-5. PubMed ID: 23270094
[TBL] [Abstract][Full Text] [Related]
23. Primary liver cancer in Sri Lanka.
Nagaratnam N; Ramachandra V; Jiffry AJ; Bhuvanendran N
J Trop Med Hyg; 1984 Aug; 87(4):185-7. PubMed ID: 6097698
[TBL] [Abstract][Full Text] [Related]
24. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
25. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
Grundmann RT; Meyer F
Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
[TBL] [Abstract][Full Text] [Related]
26. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
[TBL] [Abstract][Full Text] [Related]
27. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of cancers of the kidney in an Australian population.
Luke C; Sargent N; Pittman K; Price T; Roder D
Asian Pac J Cancer Prev; 2011; 12(11):2893-9. PubMed ID: 22393960
[TBL] [Abstract][Full Text] [Related]
30. Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.
Wu J; Yang S; Xu K; Ding C; Zhou Y; Fu X; Li Y; Deng M; Wang C; Liu X; Li L
Gastroenterology; 2018 May; 154(6):1719-1728.e5. PubMed ID: 29549041
[TBL] [Abstract][Full Text] [Related]
31. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma--a study of 51 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Acta Oncol; 1998; 37(1):77-83. PubMed ID: 9572658
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer epidemiology and survival in an Australian population.
Luke C; Price T; Karapetis C; Singhal N; Roder D
Asian Pac J Cancer Prev; 2009; 10(3):369-74. PubMed ID: 19640175
[TBL] [Abstract][Full Text] [Related]
33. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe.
Bertuccio P; Bosetti C; Levi F; Decarli A; Negri E; La Vecchia C
Ann Oncol; 2013 Jun; 24(6):1667-74. PubMed ID: 23378539
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Cholangiocarcinoma and Hepatocellular Carcinoma Incidence Trends from 1993 to 2012 in Lampang, Thailand.
Cao P; Rozek LS; Pongnikorn D; Sriplung H; Meza R
Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954902
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
37. Have incidence rates of liver cancer peaked in the United States?
Petrick JL; Florio AA; Loomba R; McGlynn KA
Cancer; 2020 Jul; 126(13):3151-3155. PubMed ID: 32294255
[TBL] [Abstract][Full Text] [Related]
38. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
[TBL] [Abstract][Full Text] [Related]
39. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
Bristol DW
Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
[TBL] [Abstract][Full Text] [Related]
40. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
